Pharmacological and therapeutic targets for Delta(9)-tetrahydrocannabinol and cannabidiol

Agriculture & Biology

• agonists 8%
• anti-inflammatory activity 9%
• antiemetics 14%
• antineoplastic agents 10%
• anxiety 10%
• appetite 10%
• cannabidiol 100%
• cannabinoid receptors 27%
• cannabinoids 24%
• Cannabis 50%
• cells 5%
• cytokines 8%
• epilepsy 12%
• extracts 9%
• glaucoma 25%
• nausea 12%
• neurons 7%
• neuroprotective effect 12%
• pain 9%
• pharmacology 10%
• receptors 18%
• sclerosis 12%
• spinal cord 9%
• tetrahydrocannabinol 88%
• therapeutics 49%
• tissues 4%

Medicine & Life Sciences

• Anti-Inflammatory Agents 6%
• Antiemetics 10%
• Antineoplastic Agents 8%
• Anxiety Disorders 8%
• Appetite Stimulants 15%
• Cannabidiol 90%
• Cannabinoid Receptor Agonists 12%
• Cannabinoid Receptor CB1 23%
• Cannabinoid Receptor CB2 25%
• Cannabinoid Receptors 11%
• Cannabinoids 21%
• Cannabis 38%
• Cytokines 5%
• Dronabinol 78%
• Epilepsy 7%
• Glaucoma 17%
• Multiple Sclerosis 8%
• Nausea 8%
• Neurons 5%
• Neuroprotective Agents 18%
• Pain Management 9%
• Pharmacology 42%
• Spinal Cord Injuries 8%
• Therapeutics 10%